We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Kumar - Weekly Dosing of the Investigational Oral Proteasome Inhibitor MLN9708 in Patients with Relapsed and/or Refractory Multiple Myeloma: Results From a Phase 1 Dose-Escalation Study
Shaji Kumar, MD
Mayo Clinic
Rochester, Minnesota, USA
12.06.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles